0ME:FRA
Twist Bioscience Corp
€169.45
0.00%
(0.00) 1D
Oct 5, 3:25:02 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Mkt. cap
13.58B
Avg. vol.
57.00
Volume
0.00
52-wk high
€173.50
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
Mkt. cap
13.58B
Avg. vol.
57.00
Volume
0.00
52-wk high
€173.50
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
Timothy Sykes
·
9 hours ago
Twist Bioscience TWST Stock Jumps On AI Drug Discovery Deals
Benzinga
·
9 hours ago
$1000 Invested In Twist Bioscience 5 Years Ago Would Be Worth This Much Today
TradingView
·
10 hours ago
Twist Bioscience Insiders Sold Shares Worth Over $9.1M
Stock Titan
·
10 hours ago
To cover stock-vesting taxes, HR SVP Paula Green sold 10,088 shares of Twist Bioscience (TWST).
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp